Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Revathi Badiginchala, Palanki Satya Dattatreya, Attili Venkata Satya Suresh, Sharanabasappa Somanath Nirni, Vindhya Vasini Andra, Deepak Bunger & Alok Chaturvedi. (2023) Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer. OncoTargets and Therapy 16, pages 215-225.
Read now
Read now
Andrea Luque-Bolivar, Erika Pérez-Mora, Victoria Eugenia Villegas & Milena Rondón-Lagos. (2020) Resistance and Overcoming Resistance in Breast Cancer. Breast Cancer: Targets and Therapy 12, pages 211-229.
Read now
Read now
Articles from other publishers (1)
Vivek P. Chavda, Lakshmi Vineela Nalla, Pankti Balar, Rajashri Bezbaruah, Vasso Apostolopoulos, Rajeev K. Singla, Avinash Khadela, Lalitkumar Vora & Vladimir N. Uversky. (2023) Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer. Cancers 15:4, pages 1023.
Crossref
Crossref